ArticleCureus2026
Chronic Inflammatory Demyelinating Polyneuropathy in a Patient With Autoimmune Autonomic Ganglionopathy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case describes a 61-year-old woman with autoimmune autonomic ganglionopathy (AAG) on long-term intravenous immunoglobulin (IVIG) who developed progressive weakness and sensory loss, ultimately diagnosed as chronic inflammatory demyelinating polyneuropathy (CIDP). Initially evaluated for Guillain-Barré syndrome, cerebrospinal fluid analysis revealed albuminocytologic dissociation without central lesions on MRI. Despite IVIG therapy, symptoms worsened, and electrodiagnostic testing demonstrated demyelination with conduction block and secondary axonal loss, confirming CIDP. Subsequent plasma exchange therapy led to gradual improvement in strength, reflexes, and ambulation while autonomic function remained stable. The coexistence of CIDP and AAG is exceedingly rare and emphasizes the potential for shared autoimmune mechanisms within the peripheral nervous system. This case highlights the importance of recognizing overlapping autoimmune neuropathies, particularly when new or progressive symptoms arise despite appropriate therapy and adapting immunomodulatory treatment accordingly to optimize long-term outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.